38 related articles for article (PubMed ID: 26305820)
1. The predictive value of human papillomavirus testing for the outcome of patients conservatively treated for stage IA squamous cell cervical carcinoma.
Costa S; Sideri M; Negri G; Venturoli S; Santini D; Casadio C; Sandri MT; Bucchi L
J Clin Virol; 2015 Sep; 70():53-57. PubMed ID: 26305820
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china.
Valdez M; Jeronimo J; Bansil P; Qiao YL; Zhao FH; Chen W; Zhang X; Kang LN; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
Int J Cancer; 2016 Mar; 138(6):1453-61. PubMed ID: 26421807
[TBL] [Abstract][Full Text] [Related]
4. [Clinical efficacy of HPV DNA chip test in the era of HPV vaccination: 1,211 cases, a single institution study].
Kahng J; Lee HJ
Korean J Lab Med; 2008 Feb; 28(1):70-8. PubMed ID: 18309258
[TBL] [Abstract][Full Text] [Related]
5. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
[TBL] [Abstract][Full Text] [Related]
6. Molecular detection of human papillomavirus and viral DNA load after radiotherapy for cervical carcinomas.
Kahla S; Kochbati L; Sarraj S; Ben Daya I; Maalej M; Oueslati R
Tumori; 2016 Oct; 102(5):521-526. PubMed ID: 26350192
[TBL] [Abstract][Full Text] [Related]
7. Detection of human papilloma virus in patients with squamous cell carcinoma of the esophagus planned for definitive chemo-radiotherapy, and a study of their clinical characteristics.
Prakash Saxena PU; Fernandes DJ; Vidyasagar MS; Singh A; Sharan K
J Cancer Res Ther; 2016; 12(2):871-5. PubMed ID: 27461666
[TBL] [Abstract][Full Text] [Related]
8. High-risk HPV genotyping in the follow-up of women treated conservatively for microinvasive cervical cancer.
Cairns M; Cuschieri KS; Cubie HA; Cruickshank ME
Int J Gynecol Cancer; 2010 Jan; 20(1):154-7. PubMed ID: 20130517
[TBL] [Abstract][Full Text] [Related]
9. Association of human papillomavirus related squamous cell carcinomas of the oropharynx and cervix.
Gazzaz MJ; Jeffery C; O'Connell D; Harris J; Seikaly H; Biron V
Papillomavirus Res; 2019 Dec; 8():100188. PubMed ID: 31629093
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, survival outcomes, and clinicopathologic factors associated with negative high risk human papillomavirus in surgical specimens of cervical cancer with pretreatment negative DNA genotype test.
Chong GO; Han HS; Park JY; Lee SD; Lee YH; Lee HJ; Hong DG; Lee YS
Int J Gynecol Cancer; 2019 Jan; 29(1):10-16. PubMed ID: 30640677
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery.
Huang HJ; Huang SL; Lin CY; Lin RW; Chao FY; Chen MY; Chang TC; Hsueh S; Hsu KH; Lai CH
Int J Gynecol Cancer; 2004; 14(4):639-49. PubMed ID: 15304160
[TBL] [Abstract][Full Text] [Related]
12. Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and Monitoring.
Kang Z; Stevanović S; Hinrichs CS; Cao L
Clin Cancer Res; 2017 Nov; 23(22):6856-6862. PubMed ID: 28899967
[No Abstract] [Full Text] [Related]
13. Detection of human papillomavirus types 16 and 18 in the exfoliated cervical cells using the polymerase chain reaction.
Nakazawa A; Inoue M; Saito J; Sasagawa T; Ueda G; Tanizawa O
Int J Gynaecol Obstet; 1992 Jan; 37(1):13-8. PubMed ID: 1346595
[TBL] [Abstract][Full Text] [Related]
14. Distribution of human papillomavirus genotypes and its relationship to clinicopathology in invasive cervical carcinoma in Zhejiang Province, China.
Chen Z; Zhou J; Chen Y; Zhu J
J Cancer Res Ther; 2018; 14(4):780-784. PubMed ID: 29970652
[TBL] [Abstract][Full Text] [Related]
15. Early posttherapy clearance of human papillomavirus and treatment response in cervical carcinoma.
Srivastava AJ; Contreras JA; Davis M; Markovina ST; Schwarz JK; Grigsby PW
Cancer; 2020 Sep; 126(18):4168-4176. PubMed ID: 32639597
[TBL] [Abstract][Full Text] [Related]
16. A case of HPV-53-related cervical cancer in an elderly patient.
Lieveld M; Padalko E; Praet M; Vanden Broeck D
Clin Interv Aging; 2014; 9():1933-4. PubMed ID: 25419122
[No Abstract] [Full Text] [Related]
17. Epidemiological characteristics of cervical cancer in a tertiary care hospital, western Saudi Arabia: A retrospective record-based analysis from 2002-2018.
Farahat FM; Faqih NT; Alharbi RS; Mudarris RI; Alshaikh SA; Al-Jifree HM
Saudi Med J; 2021 Mar; 42(3):338-341. PubMed ID: 33632914
[TBL] [Abstract][Full Text] [Related]
18. Author’s response.
Zappacosta R; Lattanzio G; Viola P; Ianieri MM; Gatta DM; Rosini S
Clin Interv Aging; 2014; 9():1935-8. PubMed ID: 25551883
[No Abstract] [Full Text] [Related]
19. Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients.
Park ST; Song MJ; Park JS; Hur SY; Lee CW
World J Surg Oncol; 2011 Jul; 9():72. PubMed ID: 21752252
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer in Morocco: epidemiological profile from two main oncological centers.
Berraho M; Bendahhou K; Obtel M; Zidouh A; Benider A; Errihani H; Nejjari C
Asian Pac J Cancer Prev; 2012; 13(7):3153-7. PubMed ID: 22994726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
